DEALS
Zhong Lun Advises on SME Board Listing of Shenzhen Salubris Pharmaceuticals Co., Ltd.
Zhong Lun Advises on SME Board Listing of Shenzhen Salubris Pharmaceuticals Co., Ltd.
Release time：2009-09-24
Voice Announcements
Shenzhen Salubris Pharmaceuticals Co., Ltd. was listed on Small and Medium Enterprise Board (SME Board) in Shenzhen on September 10, 2009.
Attorneys-at-law from Zhong Lun Law Firm Shenzhen Office, including Xu Zhigang and Wu Yi, advised on the listing. The lead underwriter and sponsor of the listing was China Merchants Securities Co., Ltd.
Shenzhen Salubris Pharmaceuticals Co., Ltd. is a professional pharmaceutical enterprise focusing on the newest generation of innovative and specialty medicine. The company mainly manufactures clopidogrel hydrogensulfate tablets, desloratadine tablets, benazepril hydrochloride tablets and azithromycin dispersible tablets.